Objective To observe the relationship between the recanalization rate of AMI patients treated with urokinase thrombolytic therapy and Thrombolysis time.

目的：观察急性心肌梗塞应用尿激酶溶栓后血管再通率与溶栓时间的相关性。

youdao

Conclusion Intravenous thrombolytic therapy in senior AMI can reduce the mortality rate, reduce the occurrence of heart failure and improve prognosis.

结论静脉溶栓治疗高龄ami可降低病死率，减少心力衰竭发生，改善预后。

youdao

Patients aged 65 to 75 who received thrombolytic therapy had a 30-day death rate of 6.8%, compared with 9.8% for patients who did not get the medication.

BBC: Heart attack drug 'can kill'